These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 24281696)

  • 41. Cancer-associated p53 tetramerization domain mutants: quantitative analysis reveals a low threshold for tumor suppressor inactivation.
    Kamada R; Nomura T; Anderson CW; Sakaguchi K
    J Biol Chem; 2011 Jan; 286(1):252-8. PubMed ID: 20978130
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DDMut: predicting effects of mutations on protein stability using deep learning.
    Zhou Y; Pan Q; Pires DEV; Rodrigues CHM; Ascher DB
    Nucleic Acids Res; 2023 Jul; 51(W1):W122-W128. PubMed ID: 37283042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. mGPfusion: predicting protein stability changes with Gaussian process kernel learning and data fusion.
    Jokinen E; Heinonen M; Lähdesmäki H
    Bioinformatics; 2018 Jul; 34(13):i274-i283. PubMed ID: 29949987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Missense3D-TM: Predicting the Effect of Missense Variants in Helical Transmembrane Protein Regions Using 3D Protein Structures.
    Hanna G; Khanna T; Islam SA; David A; Sternberg MJE
    J Mol Biol; 2024 Jan; 436(2):168374. PubMed ID: 38182301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The SAAPdb web resource: a large-scale structural analysis of mutant proteins.
    Hurst JM; McMillan LE; Porter CT; Allen J; Fakorede A; Martin AC
    Hum Mutat; 2009 Apr; 30(4):616-24. PubMed ID: 19191322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular mechanisms of disease-causing missense mutations.
    Stefl S; Nishi H; Petukh M; Panchenko AR; Alexov E
    J Mol Biol; 2013 Nov; 425(21):3919-36. PubMed ID: 23871686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platinum: a database of experimentally measured effects of mutations on structurally defined protein-ligand complexes.
    Pires DE; Blundell TL; Ascher DB
    Nucleic Acids Res; 2015 Jan; 43(Database issue):D387-91. PubMed ID: 25324307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
    Alsner J; Jensen V; Kyndi M; Offersen BV; Vu P; Børresen-Dale AL; Overgaard J
    Acta Oncol; 2008; 47(4):600-7. PubMed ID: 18465328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural convergence of unstructured p53 family transactivation domains in MDM2 recognition.
    Shin JS; Ha JH; Lee DH; Ryu KS; Bae KH; Park BC; Park SG; Yi GS; Chi SW
    Cell Cycle; 2015; 14(4):533-43. PubMed ID: 25591003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 51. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures.
    Pires DE; Blundell TL; Ascher DB
    J Med Chem; 2015 May; 58(9):4066-72. PubMed ID: 25860834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deriving a mutation index of carcinogenicity using protein structure and protein interfaces.
    Espinosa O; Mitsopoulos K; Hakas J; Pearl F; Zvelebil M
    PLoS One; 2014; 9(1):e84598. PubMed ID: 24454733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kinact: a computational approach for predicting activating missense mutations in protein kinases.
    Rodrigues CH; Ascher DB; Pires DE
    Nucleic Acids Res; 2018 Jul; 46(W1):W127-W132. PubMed ID: 29788456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Importance of surrounding residues for protein stability of partially buried mutations.
    Gromiha MM; Oobatake M; Kono H; Uedaira H; Sarai A
    J Biomol Struct Dyn; 2000 Oct; 18(2):281-95. PubMed ID: 11089649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SAAMBE: Webserver to Predict the Charge of Binding Free Energy Caused by Amino Acids Mutations.
    Petukh M; Dai L; Alexov E
    Int J Mol Sci; 2016 Apr; 17(4):547. PubMed ID: 27077847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
    Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binding of Amphipathic Cell Penetrating Peptide p28 to Wild Type and Mutated p53 as studied by Raman, Atomic Force and Surface Plasmon Resonance spectroscopies.
    Signorelli S; Santini S; Yamada T; Bizzarri AR; Beattie CW; Cannistraro S
    Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):910-921. PubMed ID: 28126403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Robust prediction of mutation-induced protein stability change by property encoding of amino acids.
    Kang S; Chen G; Xiao G
    Protein Eng Des Sel; 2009 Feb; 22(2):75-83. PubMed ID: 19054789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A neural-network-based method for predicting protein stability changes upon single point mutations.
    Capriotti E; Fariselli P; Casadio R
    Bioinformatics; 2004 Aug; 20 Suppl 1():i63-8. PubMed ID: 15262782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific DNA binding by different classes of human p53 mutants.
    Rolley N; Butcher S; Milner J
    Oncogene; 1995 Aug; 11(4):763-70. PubMed ID: 7651740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.